BRAF and metastatic melanoma: BRAF-wild type samples were majorly encompassed in the clinical global context of absent distant metastases at the time of diagnosis (78.57%, n = 11), with only a small percentage of cases corresponding to metastatic melanomas (21.42%, n = 3).